Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANDDROID: Oxytocin for Third-stage Management After Second Trimester Medical Pregnancy Termination
NCT02969447Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Oct 2016
- Primary completion
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxytocin in retained placenta (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Incidence of placental retention at 30 minutes. Started Oct 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
retained placenta
Beyond the preview
Go deeper on NCT02969447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02969447.